On March 14, ASE submitted comments to the National Coordination Office in response to a Request for Information on developing an Artificial Intelligence Action Plan. The Society recommended four key policy priorities: (1) standardize AI terminology; (2) strengthen AI development standards through rigorous FDA approvals; (3) recognize the essential role of clinician oversight; and (4) address liability concerns.
Publishing date
March 14, 2025
Related Resources
Advocacy
ASE Joins Letter of Support for the Protecting Approved Care Act
On October 23, ASE joined the Alliance of...
Advocacy
ASE Joins Coalition Letter Urging Timely FY 2027 NIH Appropriations
On October 22, ASE joined 393 other organizations...
Advocacy
ASE Submits Comments on FDA’s GenAI-Enabled Medical Device Discussion Paper
On October 16, ASE submitted comments to the...